Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — clinical trials in Belgium
13 open options
- TRIALNARECRUITING
Quantification of Hsp90 in the Human Brain
[11C]HSP990 PET dosimetry · [11C]HSP990 PET test-retest · [11C]HSP990 simplified scan protocol — 1 site
- TRIALNARECRUITING
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
ptau217 — 1 site
- TRIALPHASE2 / PHASE3RECRUITING
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
[18F]-MFBG PET CT · [18F]-FE-PE2I PET CT or PET MRI · [123I]-MIBG SPECT CT — 2 sites
- TRIALPHASE3RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
KarXT · Placebo — 154 sites
- TRIALNARECRUITING
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
UHR PET/CT scan of the brain with ¹⁸F-FDG · UHR PET/CT scan of the brain with ¹⁸F-PE2I · UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1 — 1 site
- TRIALPHASE3RECRUITING
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Acoramidis · Placebo oral tablet — 104 sites
- TRIALNARECRUITING
Hormone Replacement Trial Against ALzheimers' Disease
blood take — 1 site
- TRIALNANOT_YET_RECRUITING
Sleep Stimulation to Enhance Waste Clearance in the Brain
Closed-loop acoustic stimulation — 1 site
- TRIALPHASE2RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
MK-2214 · Placebo — 80 sites
- TRIALPHASE3RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
KarXT · Placebo — 292 sites
- TRIALPHASE3RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
KarXT — 429 sites
- TRIALNAENROLLING_BY_INVITATION
EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES
INITIAL PERIODONTAL THERAPY — 1 site
- TRIALNARECRUITING
Spatial Navigation for the Early Detection of Alzheimer's Disease.
Procedure for patients · Procedure for healthy controls — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.